Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
View ORCID ProfileMaría Velasco, Ma Isabel Galán, Ma Luisa Casas, Elia Pérez-Fernández, Diana Martínez-Ponce, Beatriz González-Piñeiro, Virgilio Castilla, View ORCID ProfileCarlos Guijarro, Working Group Alcorcón COVID-19
doi: https://doi.org/10.1101/2021.03.08.21253065
María Velasco
1Infectious Diseases and Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain. Electronic address:
Ma Isabel Galán
2Occupational Health Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Ma Luisa Casas
3Laboratory Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Elia Pérez-Fernández
4Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Diana Martínez-Ponce
2Occupational Health Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Beatriz González-Piñeiro
5Information System Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Virgilio Castilla
6Medical Director, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Carlos Guijarro
7Professor of Medicine. Rey Juan Carlos University. Internal Medicine Unit. Research, Innovation and Education Coordinator. Hospital Universitario Fundación Alcorcón, Madrid, Spain
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Full data are available at our hospital upon request
Posted March 14, 2021.
Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
María Velasco, Ma Isabel Galán, Ma Luisa Casas, Elia Pérez-Fernández, Diana Martínez-Ponce, Beatriz González-Piñeiro, Virgilio Castilla, Carlos Guijarro, Working Group Alcorcón COVID-19
medRxiv 2021.03.08.21253065; doi: https://doi.org/10.1101/2021.03.08.21253065
Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
María Velasco, Ma Isabel Galán, Ma Luisa Casas, Elia Pérez-Fernández, Diana Martínez-Ponce, Beatriz González-Piñeiro, Virgilio Castilla, Carlos Guijarro, Working Group Alcorcón COVID-19
medRxiv 2021.03.08.21253065; doi: https://doi.org/10.1101/2021.03.08.21253065
Subject Area
Subject Areas
- Addiction Medicine (337)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2607)
- Dermatology (220)
- Emergency Medicine (392)
- Epidemiology (12150)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4038)
- Geriatric Medicine (381)
- Health Economics (672)
- Health Informatics (2609)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (834)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3810)
- Nursing (208)
- Nutrition (567)
- Oncology (1997)
- Ophthalmology (580)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1103)
- Primary Care Research (443)
- Public and Global Health (6478)
- Radiology and Imaging (1380)
- Respiratory Medicine (867)
- Rheumatology (396)
- Sports Medicine (337)
- Surgery (439)
- Toxicology (52)
- Transplantation (185)
- Urology (165)